[1]
Bushra Khan et al. 2024. RISK OF ENDOMETRIAL HYPERPLASIA AND MALIGNANCY AMONG WOMEN USING TAMOXIFEN: A COMPARATIVE CLINICAL STUDY. Journal of Population Therapeutics and Clinical Pharmacology. 31, 11 (Nov. 2024), 2724–2730. DOI:https://doi.org/10.53555/2hv25555.